What is Reliefband Technologies?
Reliefband Technologies specializes in the development and commercialization of wearable neuromodulation devices designed to mitigate nausea and vomiting. By utilizing patented nerve stimulation technology, the company provides a non-invasive, drug-free alternative for patients suffering from motion sickness, morning sickness, chemotherapy-induced nausea, and anxiety-related symptoms. The firm's commitment to clinical-grade efficacy has established it as a trusted provider within the medical community, bridging the gap between traditional pharmaceutical treatments and modern, patient-centric wearable technology. Their devices are engineered to deliver rapid, reliable results without the systemic side effects often associated with anti-emetic medications.
How much funding has Reliefband Technologies raised?
Reliefband Technologies has raised a total of $7.8M across 3 funding rounds:
Private Equity
$1.8M
Private Equity
$5M
Debt
$1M
Private Equity (2015): $1.8M, investors not publicly disclosed
Private Equity (2015): $5M, investors not publicly disclosed
Debt (2017): $999K, investors not publicly disclosed
Key Investors in Reliefband Technologies
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Reliefband Technologies?
With the recent infusion of capital, Reliefband Technologies is well-positioned to accelerate its research and development pipeline and expand its footprint in the global health-tech market. The strategic focus will likely shift toward enhancing the integration of its wearable devices into broader digital health ecosystems, potentially exploring data-driven insights to personalize patient care. Furthermore, the company is expected to leverage its established clinical credibility to penetrate new therapeutic areas, potentially addressing chronic conditions that require long-term, non-pharmacological management. As the firm scales, maintaining its rigorous safety standards while optimizing manufacturing and distribution channels will be critical to sustaining its competitive advantage in the rapidly evolving landscape of medical wearables.
See full Reliefband Technologies company page
